Abstract. Previously, certain experiments have suggested that density-regulated re-initiation and release factor (DENR) could serve important roles in cancer, however, to the best of our knowledge, a comprehensive analysis of DENR and its association with cancer patient survival is lacking. The aim of the current study was to investigate the expression of DENR in multiple tumour types and to evaluate the effects of DENR on survival in malignancies. Sample expression profiles were downloaded from the Gene Expression Omnibus database. Association between DENR expression and clinicopathological features was analysed by Chi-square tests. The effects of DENR on survival were evaluated by Kaplan-Meier analysis. The results of the current study demonstrate that DENR expression was upregulated in nine cancer types. High DENR expression indicated poor prognosis of patients. The results of the present study demonstrated that DENR is highly expressed in multiple tumour types and may be used as a potential prognostic marker and therapeutic target.
Introduction
The density-regulated re-initiation and release factor (DENR) gene has been mapped to the 12q24 region of chromosome 12 in humans (1) . DENR encodes a 198 amino acid protein.
Deyo et al (1) identified that DENR encodes a novel protein, the expression of which is upregulated in cells cultured at high density, in comparison with those grown at low density. Cell-cell contact is similarly important to immune system function and malignant tumour metastasis (2, 3) . Certain studies have suggested that alterations in cell density lead to changes in the biology of a cell, including modulated expression of differentiation properties of LLC-PK1 cells (4) and gene transcriptional activity, including MYC proto-oncogene, BHLH transcription factor (5) . One potential initiating mechanism for DENR increase is cell contact itself. Reinert et al (6) revealed novel actions of MCT1, the monocarboxylate transporter 1 gene located at chromosome Xq22-24 (7) , whose protein product is comprised of an SUI1 domain involving the translation initiation factor, eukaryotic initiation factor 2 (eIF2) (8) . Reinert et al (6) identified that MCT1 is a cap-binding protein that recruits and interacts with DENR and subsequently, modifies the mRNA translational profile. Using a yeast two-hybrid method, MCT1 was demonstrated to interact with DENR involving the SUI1 domain, which may play a role in the pathogenesis of human breast carcinoma (6) (7) (8) (9) . Skabkin et al (10) studied the interactions of Ligatin and MCT-1/DENR and identified related proteins that singly (Ligatin) or jointly (MCT-1 and DENR) elevate efficient eIF2-independent recruitment of Met-tRNA to 40S/mRNA complexes, and demonstrated that MCT-1/DENR could elevate the release of mRNA. A report by Schleich et al (11) suggested that DENR affects the translation of mRNAs involved in cell proliferation. Recently, a study identified that DENR was highly associated with glioma susceptibility (12) . Although, to the best of our knowledge, the specific role of DENR has not been elucidated in humans, these studies suggest an important role in cancer. However, a comprehensive analysis of DENR expression and its relation to the survival of cancer patients is lacking.
The current study evaluated the expression of DENR in normal and cancerous tissues in humans. In addition, the current study analysed the significance of DENR in cancer prognosis using publicly available datasets of gene expression coupled with clinical outcomes. Data pre-processing and representation. Samples were defined as either carcinoma or normal. Datasets from the nine cancer types were normalised by the RMA algorithm (26) using R statistical 3.1 software (https://www.r-project.org/). Expression values of DENR were dichotomised into low-and high-expression groups using the median as a cut-off value.
Data analysis. Data were analysed using R statistical 3.1 software. Paired or unpaired t-tests were used to analyse expression differences between carcinoma and normal groups. Associations between gene expression and clinicopathological characteristics were evaluated by Chi-square test. Overall survival and recurrence-free survival were evaluated by Kaplan-Meier analysis and a log-rank test. GSEA was used to predict the gene sets modulated by DENR. Expression differences were analysed between normal and carcinoma tissues by paired or unpaired t-tests with threshold values of P<0.05. P<0.05 was considered to indicate a statistically significant difference. Bars indicate the median and the interquartile range of the dataset analysis in the present study.
Results

DENR upregulation in multiple cancers.
To examine DENR expression in human cancers the tumour expression profiles were downloaded and normalised by RMA. As demonstrated in Fig. 1 
Associations between DENR expression and clinicopathological features of patients with nine common cancer types.
The data summarised in Table I reveal significant associations between DENR expression and clinicopathological features of patients with multiple cancer types, including hepatocellular carcinoma (primary data from GSE14520), gastric cancer (primary data from GSE15459), lung cancer (primary data from GSE30219), breast cancer (primary data from TCGA), kidney cancer (primary data from TCGA), rectal cancer (primary data from TCGA) and pancreatic cancer (primary data from TCGA). Associations between DENR expression and clinicopathological features for head and neck cancer (primary data from GSE9844) including, age, gender and lymph node metastases were not significant. In addition, data involving clinicopathological features for vulvar cancer in public databases were not available. The results presented in Table I demonstrate that increased DENR expression was significantly associated with more aggressive phenotypes. This was measured by the American Joint Committee on Cancer (AJCC) classification of malignant tumours including T, N, M and TNM stages (27) . DENR expression was significantly higher in advanced AJCC tumour stages than in early tumour stages in multiple cancers including hepatocellular cancer, lung cancer, breast cancer, kidney cancer and rectal cancer. DENR expression was significantly elevated in lymph node metastases compared to that in non-lymph node metastases in lung cancer. High DENR expression was positively associated with histological tumour subtype and Lauren classification (27) in gastric cancer. DENR expression was significantly increased in high α-fetoprotein (AFP) tumours compared with low AFP tumours in hepatocellular cancer.
Association of DENR expression with survival outcome in gastric cancer, hepatocellular carcinoma, lung cancer, kidney cancer and laryngeal cancer. DENR expression (low DENR, n=96; high DENR, n=96) in gastric cancer tissues (primary data from GSE15459) was significantly associated with reduced overall survival (χ 2 =5.1 and P=0.0235 in log-rank test; Fig. 2A) . Expression of DENR (low DENR, n=110; high DENR, n=111) in hepatocellular carcinoma tissues (primary data from GSE14520) was significantly associated with worse overall survival (χ 2 =4.6 and P=0.0329 in log-rank test; Fig. 2B ). In lung cancer tissues (primary data from GSE30219), DENR expression (low DENR, n=146; high DENR, n=147) was significantly associated with poor overall survival Table I . Correlation between DENR expression and clinicopathological features of patients with nine common cancer types. Fig. 2C ). For lung cancer (primary data from GSE30219), expression of DENR (low DENR, n=146; high DENR, n=147) was significantly associated with diminished recurrence-free survival (χ 2 =17.1 and P=3.6x10
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-05 in log-rank test; Fig. 2D ). DENR expression (low DENR, n=33; high DENR, n=33) in kidney cancer tissues (primary data from TCGA) was significantly associated with poor overall survival (χ 2 =4.4 and P=0.0351 in log-rank test; Fig. 2E ). DENR levels (low DENR, n=53; high DENR, n=54) in laryngeal cancer tissues (primary data from GSE27020) were significantly associated with reduced recurrence-free survival (χ 2 =4.8 and P=0.0284 in log-rank test; Fig. 2F ). Clinicopathological feature data for head and neck cancer and vulvar cancer in public vulvar carcinoma databases were either non-significant or not available.
Data analysed by Chi-square test. DENR, density-regulated re-initiation and release factor; AFP, α-fetoprotein; AJCC, American Joint Committee on Cancer; CLIP, Cancer of the Liver Italian Program; TNM, tumour-node-metastases; T, tumour; N, lymph node; n, number of samples; TCGA, The Cancer Genome Atlas. In summary, these results demonstrate that high DENR expression is indicative of a poor prognosis for patients with hepatocellular carcinoma, gastric cancer, kidney cancer, laryngeal cancer and lung cancer.
GSEA for lung cancer tissues with high DENR expression. Fig. 3 demonstrates the results of GSEA for lung cancer tissues with high DENR expression (primary data from GSE30219). The curated gene set was used as an example dataset. The results revealed that enriched gene sets were associated with CELL_CYCLE [P<0.001, false discovery rate (FDR)=0.068, enrichment score (ES)=0.793; Fig. 3A] , CR_REPAIR (cancer-related DNA repair) (P=0.012, FDR=0.071, ES=0.670; Fig. 3B ), DNA_DAMAGE_SIGNALLING (P= 0.002, FDR=0.056, ES=0.558; Fig. 3C ) and MRNA_SPLICING (P<0.001, FDR= 0.003, ES= 0.644; Fig. 3D ). These findings indicated that DENR regulates cell cycle, cancer-related DNA repair, DNA damage signalling and mRNA splicing activities.
Discussion
In the current study, it has been demonstrated that DENR expression is upregulated in different cancer tissues compared with that observed in normal tissues. Deyo et al (1) demonstrated that the DENR gene maps to human chromosome 12. Skabkin et al (28) revealed that the release of tRNA and mRNA is associated with eukaryotic translation initiation factor 1 (eIF1)/eIF1A, Ligatin or MCT-1/DENR. Furthermore, Figure 2 . Association of DENR expression with patient prognosis in gastric cancer, hepatocellular carcinoma, lung cancer, kidney cancer and laryngeal cancer. The association was investigated by Kaplan-Meier analysis and log-rank test. Overall survival of (A) patients with gastric cancer (data from GSE15459) and (B) patients with hepatocellular carcinoma (data from GSE14520). (C) Overall survival and (D) recurrence-free survival of patients with lung cancer (data from GSE 30219). (E) Overall survival of patients with kidney cancer (data from TCGA) and (F) recurrence-free survival of patients with laryngeal cancer (data from GSE27020). DENR, density-regulated re-initiation and release factor; GSE, gene set enrichment. (11) demonstrated that the regulation of the translation of a specific set of mRNAs is associated with DENR. The results of GSEA for lung cancer tissues with high DENR expression identified in the current study established that enriched gene sets were associated with the MRNA_ SPLICING categorisation. These findings indicated that DENR regulates mRNA splicing. A previous study disclosed that cells harbour a previously unappreciated translational control system that involves DENR and exerts a key role in tissue development and supporting cellular proliferation (11) . The current study demonstrates that DENR is associated with cell cycle, CR_REPAIR (cancer-related DNA repair), DNA damage signalling, disrupted DNA replication, DNA repair and cell cycle progression, which promotes uncontrolled proliferation of tumour cells (29) . Similarly, the current study identified that elevated DENR expression was significantly associated with advanced AJCC tumour stages in multiple cancer types including hepatocellular cancer, lung cancer, breast cancer, kidney cancer and rectal cancer.
Schleich et al
Advanced tumour stage, tumour size and lymph node metastasis are each indicative of poor prognosis (30, 31) . High DENR expression was associated with these disadvantageous features in the current study and was also associated with poor overall survival or recurrence-free survival in hepatocellular carcinoma, gastric cancer, kidney cancer, laryngeal cancer and lung cancer. In hepatocellular carcinoma, DENR expression was significantly increased in high AFP tumours compared with low AFP tumours. A recent study suggested that AFP is Figure 3 . GSEA for lung cancer tissues with high DENR expression (data from GSE30219). GSEA revealed that the enriched gene sets were associated with (A) cell cycle, (B) CR_REPAIR (cancer DNA related repair), (C) DNA damage signalling and (D) mRNA splicing. GSEA, gene set enrichment analysis; DENR, density-regulated re-initiation and release factor. associated with malignant hepatic tumours (32) . The current study revealed high DENR expression was positively associated with the histological tumour invasive subtype and metabolic subtype in gastric cancer. A previous study demonstrated that invasive subtype is associated with malignant gastric cancer and poor prognosis (33) . The current study revealed that DENR expression in gastric cancer tissues is significantly associated with overall survival. High DENR expression is indicative of poor prognosis for patients with gastric cancer.
In conclusion, the current study demonstrated that DENR is highly expressed in multiple cancer types and is associated with poor survival of patients with hepatocellular carcinoma, gastric cancer, kidney cancer, laryngeal cancer and lung cancer. Elevated expression of DENR may contribute to tumourigenesis and affect clinical outcome.
